- Recursion unveils post–combination technology–enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programs
- Platform will focus on first [...] Read more »
Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates
JERUSALEM, Nov. 08, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptides and small therapeutic proteins, today [...] Read more »
Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences
WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical–stage global biopharmaceutical company committed to being a [...] Read more »
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
- REC–3964 is Recursion’s first new chemical entity developed using the RecursionOS.
- REC–3964 represents a novel, non–antibiotic approach with a unique mechanism of action that binds and blocks [...] Read more »
Fortrea publie son premier rapport de Responsabilité Sociale d’Entreprise
DURHAM, Caroline du Nord, 18 oct. 2024 (GLOBE NEWSWIRE) — Read more »
Fortrea Publica Primeiro Relatório de Responsabilidade Social Corporativa
DURHAM, N.C., Oct. 17, 2024 (GLOBE NEWSWIRE) — A Read more »
Fortrea veröffentlicht ersten Bericht zur sozialen Verantwortung des Unternehmens
DURHAM, N.C., Oct. 18, 2024 (GLOBE NEWSWIRE) — Read more »
Fortrea Releases Inaugural Corporate Social Responsibility Report
DURHAM, N.C., Oct. 17, 2024 (GLOBE NEWSWIRE) — Read more »
Curia Se Compromete Ao Padrão SBTi Net-Zero
Albany, NY, Oct. 11, 2024 (GLOBE NEWSWIRE) — A Curia, uma organização líder em contratos de pesquisa, desenvolvimento e fabricação, anunciou hoje seu compromisso de estabelecer [...] Read more »
Curia s’engage envers la norme de neutralité carbone « net zéro » de la SBTi
Albany, New York, 11 oct. 2024 (GLOBE NEWSWIRE) — Curia, une organisation de recherche, de développement et de fabrication sous contrat de première importance fait part ce [...] Read more »